| |
| |
|
| Insider
Information: |
Rubin Marc |
| Relationship: |
Director |
| City: |
So. San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
598,717 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$301,091 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
598,717 |
|
|
| Total
Value |
$301,091 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Titan Pharmaceuticals Inc |
TTNP |
Executive Chairman, Di... |
2018-09-21 |
556,317 |
|
0 |
Premium* |
|
|
Curis Inc |
CRIS |
Director |
2019-01-23 |
28,819 |
2010-12-10 |
0 |
Premium* |
|
|
Galectin Therapeutics Inc |
GALT |
Director |
2019-02-22 |
13,581 |
2011-10-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2019-02-22 |
4 |
AS |
$6.02 |
$5,175 |
D/D |
(859) |
13,581 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2019-02-22 |
4 |
OE |
$2.39 |
$2,053 |
D/D |
859 |
14,440 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2019-02-21 |
4 |
AS |
$6.00 |
$303,026 |
D/D |
(50,326) |
13,581 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2019-02-21 |
4 |
OE |
$2.39 |
$103,549 |
D/D |
43,326 |
56,907 |
0 |
- |
|
| CRIS |
Curis Inc |
Director |
– • – |
2019-01-23 |
4 |
AS |
$1.05 |
$19,477 |
D/D |
(18,500) |
28,819 |
0 |
- |
|
| TTNP |
Titan Pharmaceuticals Inc |
Executive Chairman |
• • – |
2018-09-21 |
4 |
B |
$0.25 |
$100,000 |
D/D |
400,000 |
556,317 |
2.81 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2018-09-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,000 |
32,481 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2018-09-04 |
4 |
AS |
$6.58 |
$78,256 |
D/D |
(11,900) |
20,581 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2018-08-30 |
4 |
AS |
$6.08 |
$353,312 |
D/D |
(58,100) |
26,481 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2018-08-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
29,000 |
84,581 |
0 |
- |
|
| CRIS |
Curis Inc |
Director |
– • – |
2018-01-22 |
4 |
A |
$0.00 |
$0 |
D/D |
185,000 |
236,596 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2017-12-08 |
4 |
B |
$1.85 |
$12,972 |
D/D |
7,000 |
55,581 |
2.39 |
- |
|
| CRIS |
Curis Inc |
Director |
– • – |
2017-11-16 |
4 |
B |
$0.98 |
$24,500 |
D/D |
25,000 |
51,596 |
2.39 |
- |
|
| TTNP |
Titan Pharmaceuticals Inc |
Executive Chairman |
• • – |
2016-01-11 |
4 |
B |
$3.25 |
$16,250 |
D/D |
5,000 |
156,317 |
2.81 |
- |
|
| TTNP |
Titan Pharmaceuticals Inc |
Executive Chairman |
• • – |
2015-08-28 |
4 |
B |
$0.72 |
$35,750 |
D/D |
50,000 |
832,200 |
2.81 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2015-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
2,768 |
48,581 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2015-04-08 |
4 |
A |
$0.00 |
$0 |
D/D |
28,367 |
45,813 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2015-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
11,112 |
17,446 |
0 |
- |
|
| TTNP |
Titan Pharmaceuticals Inc |
Executive Chairman |
• • – |
2014-10-09 |
4 |
B |
$0.48 |
$48,200 |
D/D |
100,000 |
707,200 |
2.81 |
- |
|
| TTNP |
Titan Pharmaceuticals Inc |
Executive Chairman |
• • • |
2014-02-12 |
4 |
A |
$0.66 |
$66,000 |
D/D |
100,000 |
682,200 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2013-12-04 |
4 |
B |
$8.69 |
$26,070 |
D/D |
3,000 |
6,334 |
2.39 |
- |
|
| TTNP |
Titan Pharmaceuticals Inc |
Executive Chairman |
• • – |
2013-06-17 |
4 |
B |
$0.45 |
$22,690 |
D/D |
50,000 |
463,400 |
2.81 |
- |
|
| TTNP |
Titan Pharmaceuticals Inc |
Executive Chairman |
• • – |
2011-11-18 |
4 |
B |
$1.27 |
$48,918 |
D/D |
38,400 |
413,400 |
2.81 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Director |
– • – |
2011-10-18 |
4 |
B |
$0.96 |
$19,200 |
D/D |
20,000 |
20,000 |
2.39 |
- |
|
| CRIS |
Curis Inc |
Director |
– • – |
2010-12-10 |
4 |
B |
$1.89 |
$50,266 |
D/D |
26,596 |
26,596 |
2.39 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
